Dec 11 (Reuters) - Phathom Pharmaceuticals PHAT.O:
PHATHOM PHARMACEUTICALS SUBMITS CITIZEN PETITION TO FDA SEEKING CORRECTION OF ORANGE BOOK LISTINGS FOR VOQUEZNA® (VONOPRAZAN) TABLETS
PHATHOM: PETITION REQUESTS CORRECTION OF ORANGE BOOK LISTINGS FOR VOQUEZNA 10 MG,20 MG TABLETS TO ACCURATELY REFLECT 10-YEAR NCE EXCLUSIVITY PERIOD
PHATHOM PHARMACEUTICALS INC: EXCLUSIVITY PERIOD IS UNTIL MAY 3, 2032
Source text: ID:nGNXMt0NF
Further company coverage: PHAT.O
((Reuters.Briefs@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。